The Harris Center for Mental Health and IDD

Health Technology

Rudolf Riester GmbH | January 29, 2024

Rudolf Riester GmbH, a global leader in medical technology, proudly announces the full market launch of its comprehensive Telemedicine offering. Already in active use across Europe, the Middle East, and Africa, the solution from the trusted Riester brand delivers industry-leading quality and versatility through integration of a broad range of medical devices to meet the needs of diverse user scenarios. "Since its founding 75 years ago, Riester has been a pioneer in providin...

Health Technology

Sense Biodetection | September 02, 2022

Global molecular diagnostics innovator, Sense Biodetection announced it has entered into a strategic agreement with TECOmedical for the non-exclusive distribution of Sense’s Veros COVID-19, the first test on the rapid, instrument-free, point-of-care Veros molecular testing platform. The self-contained, single-use Veros COVID-19 product produces PCR-quality results in about 15 minutes, unconstrained by a reader or need for external power. TECOmedical, a Eurobio Scientific Compa...

HealthITAnalytics | March 02, 2020

A machine learning algorithm can mine EHR data and discover novel associations between common chronic diseases and lesser-known conditions, which could support earlier monitoring or medical intervention, according to a study published in PLOS One. The use of EHRs in large health systems offers the opportunity to conduct population-level analyses that explore disease progression. The team wanted to identify novel comorbidities from routinely collected, anonymized EHRs. Researchers developed a mac...

Humana, NQF | April 22, 2020

The COVID-19 pandemic is putting a spotlight on why it’s critical for population-based models to consider the impacts of patients’ social needs, experts say. William Shrank, M.D., chief medical officer at Humana, and Shantanu Agrawal, M.D., CEO of the National Quality Forum, co-authored an analysis this week that argues social risks should be weighed alongside clinical risks in population-based payment models. Shrank said that the coronavirus pandemic is further highlighting the impa...